Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.
Saved in:
| Title: | Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib. |
|---|---|
| Authors: | Zhu Z; Pfizer Inc, La Jolla, CA, USA., Turner NC; Royal Marsden Hospital and Institute of Cancer Research, London, UK. nick.turner@icr.ac.uk., Loi S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., André F; Institut Gustave Roussy, INSERM and Université Paris Saclay, Villejuif, France., Martin M; Instituto para la Investigación Sanitaria Gregorio Marañón, Ciberonc, Universidad Complutense, Madrid, Spain., Diéras V; Centre Eugène Marquis, Rennes Cedex, France., Gelmon KA; British Columbia Cancer, Vancouver, BC, Canada., Harbeck N; Brustzentrum der Universität München (LMU), München, Germany., Zhang C; Pfizer Inc, La Jolla, CA, USA., Cao JQ; Pfizer Inc, La Jolla, CA, USA., Yan Z; Pfizer Inc, La Jolla, CA, USA., Lu DR; Pfizer Inc, La Jolla, CA, USA., Wei P; Pfizer Inc, La Jolla, CA, USA., VanArsdale TL; Pfizer Inc, La Jolla, CA, USA., Rejto PA; Pfizer Inc, La Jolla, CA, USA., Huang X; Pfizer Inc, La Jolla, CA, USA., Rugo HS; University of California San Francisco Helen Diller Comprehensive Center, San Francisco, CA, USA., Loibl S; German Breast Group, Neu-Isenburg, Germany., Cristofanilli M; Weill Cornell Medicine, New York, NY, USA., Finn RS; David Geffen School of Medicine at UCLA, Santa Monica, CA, USA., Liu Y; Pfizer Inc, La Jolla, CA, USA. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2022 Aug 16; Vol. 6 (1), pp. 56. Date of Electronic Publication: 2022 Aug 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
